[go: up one dir, main page]

MA25590A1 - ACTIVE AGENT FOR DRY POWDER DELIVERY - Google Patents

ACTIVE AGENT FOR DRY POWDER DELIVERY

Info

Publication number
MA25590A1
MA25590A1 MA25762A MA25762A MA25590A1 MA 25590 A1 MA25590 A1 MA 25590A1 MA 25762 A MA25762 A MA 25762A MA 25762 A MA25762 A MA 25762A MA 25590 A1 MA25590 A1 MA 25590A1
Authority
MA
Morocco
Prior art keywords
active agent
dry powder
powder delivery
delivery
dry
Prior art date
Application number
MA25762A
Other languages
French (fr)
Inventor
Clark Andrew
Chang Kuo Mei
John Aldous Barry
Lalor Cecily
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of MA25590A1 publication Critical patent/MA25590A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MA25762A 1998-09-14 1999-09-09 ACTIVE AGENT FOR DRY POWDER DELIVERY MA25590A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
MA25590A1 true MA25590A1 (en) 2002-12-31

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25762A MA25590A1 (en) 1998-09-14 1999-09-09 ACTIVE AGENT FOR DRY POWDER DELIVERY

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
WO2000075281A2 (en) 1999-06-09 2000-12-14 University Technology Corporation Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (en) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション Delivery of drug ester by the prescribed inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7182961B2 (en) 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
AU2003215396B2 (en) 2002-02-25 2010-04-08 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2006513139A (en) * 2002-07-03 2006-04-20 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド Central airway administration for systemic delivery of therapeutic agents
WO2004060352A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005237523A1 (en) * 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
UA95903C2 (en) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Trans carotenoids, their synthesis, formulation and uses
KR20070110418A (en) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 Particles and Formulations Containing the Particles
MX383536B (en) 2005-10-26 2025-03-14 Cydex Pharmaceuticals Inc SULFOALKYL ETHER-CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARING SAME.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
CN101541311B (en) * 2006-10-25 2013-01-23 大日本住友制药株式会社 Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
KR101570131B1 (en) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 Use of bipolar transcarotenoids for the treatment and prevention of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
JP2011502125A (en) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー A new class of treatments that promote small molecule diffusion
PL2432502T3 (en) 2009-05-20 2018-05-30 Aeras Stable, spray dried, immunogenic, viral compositions
CN108464976A (en) 2009-06-22 2018-08-31 扩散药品有限公司 Diffusion promotes compound and its independent or application together with Thrombolytic Drugs
WO2011152869A1 (en) 2010-06-02 2011-12-08 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
CA2866230C (en) 2012-05-03 2020-08-18 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (en) 2014-10-31 2020-12-21 Univ Monash POWDER FORMULATION
CN115089569A (en) 2016-03-24 2022-09-23 扩散药品有限公司 Use of bipolar trans carotenoids in conjunction with chemotherapy and radiation therapy for the treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
PT954282E (en) * 1997-01-16 2005-06-30 Massachusetts Inst Technology PREPARATION OF PARTICLES FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
EA003476B1 (en) 2003-06-26
CO5130023A1 (en) 2002-02-27
SA99200718B1 (en) 2006-11-04
IS5878A (en) 2001-03-05
EP1117442A1 (en) 2001-07-25
SK3442001A3 (en) 2001-11-06
GEP20043257B (en) 2004-06-25
UY25711A1 (en) 1999-11-17
LT4897B (en) 2002-02-25
AU6039799A (en) 2000-04-03
DZ2892A1 (en) 2003-12-15
HUP0103837A2 (en) 2002-05-29
ID28845A (en) 2001-07-05
HRP20010189A2 (en) 2005-04-30
HUP0103837A3 (en) 2002-11-28
AU753014B2 (en) 2002-10-03
CN1317977A (en) 2001-10-17
OA11781A (en) 2005-07-26
TWI226248B (en) 2005-01-11
KR20010075063A (en) 2001-08-09
NO20011251D0 (en) 2001-03-13
LT2001021A (en) 2001-11-26
TR200101182T2 (en) 2001-09-21
PL346768A1 (en) 2002-02-25
LV12658B (en) 2001-09-20
CA2343920A1 (en) 2000-03-23
MY129282A (en) 2007-03-30
IL141562A (en) 2007-07-24
HN1999000159A (en) 1999-11-11
EA200100300A1 (en) 2001-10-22
PA8481901A1 (en) 2002-04-25
GT199900156A (en) 2001-03-07
YU24201A (en) 2003-08-29
EE200100151A (en) 2002-06-17
ZA200101995B (en) 2002-03-11
AR022090A1 (en) 2002-09-04
NO20011251L (en) 2001-04-17
AP2001002093A0 (en) 2001-03-31
PE20001061A1 (en) 2000-10-08
IL141562A0 (en) 2002-03-10
AP1374A (en) 2005-02-28
BR9913722A (en) 2001-05-29
UA76085C2 (en) 2006-07-17
HK1042231A1 (en) 2002-08-09
JP2002524535A (en) 2002-08-06
PL195574B1 (en) 2007-10-31
WO2000015262A1 (en) 2000-03-23
LV12658A (en) 2001-05-20
NZ510168A (en) 2003-09-26
BG105430A (en) 2001-12-29
CZ2001829A3 (en) 2001-09-12
TNSN99173A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
MA25590A1 (en) ACTIVE AGENT FOR DRY POWDER DELIVERY
MA26033A1 (en) ACTIVE AEROSOL DELIVERY AGENT
IL149554A0 (en) Fungicidal combinations of active substances
IS5248A (en) Pharmaceutical formulations containing voriconazole
DE60039829D1 (en) powder spray
IS6263A (en) Pharmaceutical formulations containing tripeptide
DE69826704D1 (en) PLEUROMUTLIN DERIVATIVES AS AN ANTIMICROBIAL ACTIVE AGENT
GB0216125D0 (en) Fibers providing controlled active agent delivery
DE69923076D1 (en) TRANSTHORACOAL MEDICAMENT DELIVERY
EP1487417A4 (en) Dry powder medicament formulations
EE200000595A (en) Delivery of the active ingredient to the carrier matrix
NO20015670L (en) Improved pharmaceutical formulations
PT1227724E (en) HERBICIDE AGENT
PL349862A1 (en) Fungicidal active substance combinations
DE59902159D1 (en) ACTIVE MICROMIC
PL355623A1 (en) Fungicidally active substance combinations
NO20005880D0 (en) Bioreductive cytotoxic agents
FR2797156B1 (en) POWDER DISPENSER
DE60019505D1 (en) Microbicidal active substances
ES1048018Y (en) PACK OF CIGARETTES.
ZA200202759B (en) Synergistic herbicidal active substance combinations.
HUP0201986A2 (en) Fungicidal combinations of active substances
FR2796699B1 (en) ROTARY POWDER DISPENSER
GB2351221B (en) Animal cage
ZA200202777B (en) Dosage unit for dry powder medicament.